Literature DB >> 8891157

Prenatal and postpartum pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) and didanosine (dideoxyinosine) in pigtailed macaques (Macaca nemestrina).

A Odinecs1, C Pereira, C Nosbisch, J D Unadkat.   

Abstract

Stavudine (5 mg/kg of body weight; n = 7) or didanosine (3.2 mg/kg; n = 4) was administered as an intravenous bolus to pregnant pigtailed macaques (Macaca nemestrina) near term and 4 to 5 weeks postpartum. No significant differences were found between the prenatal and postpartum total plasma drug clearance, steady-state volume of distribution, terminal plasma drug half-life, mean body residence time, or recovery of unchanged drug in urine. These data indicate that pregnancy does not affect the pharmacokinetics of stavudine or didanosine in M. nemestrina.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891157      PMCID: PMC163547     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  In vivo maternal-fetal pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) in pigtailed macaques (Macaca nemestrina).

Authors:  A Odinecs; C Nosbisch; R D Keller; W L Baughman; J D Unadkat
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

2.  Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection.

Authors:  N R Hartman; R Yarchoan; J M Pluda; R V Thomas; K S Marczyk; S Broder; D G Johns
Journal:  Clin Pharmacol Ther       Date:  1990-05       Impact factor: 6.875

3.  Alternatives to chronic restraint of nonhuman primates.

Authors:  W R Morton; G H Knitter; P M Smith; T G Susor; K Schmitt
Journal:  J Am Vet Med Assoc       Date:  1987-11-15       Impact factor: 1.936

4.  LAGRAN program for area and moments in pharmacokinetic analysis.

Authors:  M L Rocci; W J Jusko
Journal:  Comput Programs Biomed       Date:  1983-06

5.  Drug disposition and pharmacokinetics in the maternal-placental-fetal unit.

Authors:  B Krauer; F Krauer; F E Hytten
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

6.  Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virus.

Authors:  M M Mansuri; M J Hitchcock; R A Buroker; C L Bregman; I Ghazzouli; J V Desiderio; J E Starrett; R Z Sterzycki; J C Martin
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

7.  Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rhesus monkeys.

Authors:  R F Schinazi; F D Boudinot; K J Doshi; H M McClure
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 8.  Treatment of AIDS with combinations of antiretroviral agents.

Authors:  T C Merigan
Journal:  Am J Med       Date:  1991-04-10       Impact factor: 4.965

9.  Pharmacokinetics of zidovudine (azidothymidine). III. Effect of pregnancy.

Authors:  A Lopez-Anaya; J D Unadkat; L A Schumann; A L Smith
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

10.  Disposition in animals of a new anti-HIV agent: 2',3'-didehydro-3'-deoxythymidine.

Authors:  J W Russell; V J Whiterock; D Marrero; L J Klunk
Journal:  Drug Metab Dispos       Date:  1990 Mar-Apr       Impact factor: 3.922

View more
  2 in total

Review 1.  Antiretroviral therapy in pregnancy: a focus on safety.

Authors:  G P Taylor; N Low-Beer
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans.

Authors:  Nadia O Bamfo; Chelsea Hosey-Cojocari; Leslie Z Benet; Connie M Remsberg
Journal:  Pharm Res       Date:  2021-07-12       Impact factor: 4.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.